English  |  正體中文  |  简体中文  |  2831143  
???header.visitor??? :  33157701    ???header.onlineuser??? :  1037
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"tsai ac"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 32  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2020-06-19 Tubular transcriptional co-activator with PDZ-binding motif protects against ischemic acute kidney injury Wu, CL;Chang, CC;Yang, TH;Tsai, AC;Wang, JL;Chang, CH;Tarng, DC
亞洲大學 2017-07 Predicted factors for older Taiwanese to be healthy octogenarians: Results of an 18-year national cohort study Hsu WC;Hsu WC;Tsai AC;Tsai AC;Chen YC;Chen YC;王俊毅;Jiun-Yi Wang;
國家衛生研究院 2014-05 Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells Lee, HY;Tsai, AC;Chen, MC;Shen, PJ;Cheng, YC;Kuo, CC;Pan, SL;Liu, YM;Liu, JF;Yeh, TK;Wang, JC;Chang, CY;Chang, JY;Liou, JP
國家衛生研究院 2014-04 Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL
臺北醫學大學 2014 Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells Lee, HY;Tsai, AC;Chen, MC;Shen, PJ;Cheng, YC;Kuo, CC;Pan, SL;Liu, YM;Liu, JF;Yeh, TK;Wang, JC;Chang, CY;Chang, JY;Liou, JP.
臺北醫學大學 2014 In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL
臺北醫學大學 2014 Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL.
臺北醫學大學 2014 Synergistic Interaction between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer Cells In Vitro and In Vivo Chen, CH;Chen, MC;Wang, JC;Tsai, AC;Chen, CS;JP*, Liou;SL*, Pan;CM*, Teng
臺北醫學大學 2014 A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulaiton of TIMP3 expression Wang, CY;Liou, JP;Tsai, AC;Lai, MJ;Liu, YM;Lee, HY;Wang, JC;SL*, Pan;CM*, Teng
臺北醫學大學 2014 In vitro and in vivo antitumor effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL

Showing items 1-10 of 32  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page